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Between 1987 and 1999, salmon consump-
tion increased annually at a rate of 14% in
the European Union and 23% in the United
States (Charron 1999). Currently, more than
half the salmon sold globally is farm raised,
primarily in northern Europe, Chile, Canada,
and the United States. The annual global
production of farmed salmon (predominantly
Atlantic salmon) has risen from 27,000 to
> 1 million metric tons during the past two
decades [Food and Agriculture Organization
of the United Nations (FAO) 2004].
The health beneﬁts, primarily in terms of
prevention of sudden cardiac death, of eating
fish such as salmon have been well docu-
mented (Daviglus et al. 2002; Harper and
Jacobson 2001); however, both farmed and
wild salmon have been shown to accumulate
a variety of toxic pollutants, some of which
may counteract the beneficial effects of the
omega-3 fatty acids present in fish and may
increase risk of other diseases (Hites et al.
2004a, 2004b). One such pollutant is dioxin,
which has been associated with numerous
adverse health effects.
The most potent dioxin congener, 2,3,7,8-
tetrachlorodibenzo-p-dioxin (TCDD), is clas-
siﬁed by the International Agency for Research
on Cancer as a group I carcinogen (known to
cause cancer in humans), a classiﬁcation that
was reconfirmed recently (Steenland et al.
2004). The U.S. Environmental Protection
Agency (EPA) has classified TCDD as “car-
cinogenic to humans,” and the agency has
characterized complex mixtures of dioxins as
likely human carcinogens (U.S. EPA 2002).
TCDD increases the risk of all cancers
(Crump et al. 2002), including soft-tissue sar-
comas (Kang et al. 1987), lung and liver can-
cers (Steenland et al. 2004), and breast cancer
(Warner et al. 2002).
Complex mixtures of dioxins [hereafter
“dioxin” refers to dioxin-like compounds
(DLCs) as deﬁned below] also elicit a variety
of noncancer effects. Dioxin is an immuno-
suppressive agent, and the immune system
appears to be one of the systems most sensitive
to its effects (Birnbaum and Tuomisto 2000).
Highly exposed residents of Seveso, Italy,
showed a significant and dose-dependent
reduction of plasma IgG levels (Baccarelli
et al. 2002). Dutch children exposed peri-
natally to dioxin showed decreased allergies
but altered lymphocytes and thrombocytes
(Ten Tusscher et al. 2003) and had lower
antibody levels to mumps and measles at
preschool age and higher incidence of recur-
rent middle-ear infections and chicken pox
(Weisglas-Kuperus et al. 2000). Van Den
Heuvel et al. (2002) have shown that Flemish
adolescents exposed to polychlorinated
biphenyls (PCBs) and dioxins are more sus-
ceptible to infectious diseases.
Dioxin also alters behavior in laboratory
animals (Hojo et al. 2002) and humans
(Vreugdenhil et al. 2002). Perinatally exposed
monkeys showed decrements in ability to learn
discrimination tasks (Schantz and Bowman
1989), and U.S. Air Force Ranch Hand
Veterans with high exposure demonstrated
reduced memory function (Barrett et al.
2001). Dioxins have been shown to increase
risk of cardiovascular disease in laboratory ani-
mals (Lind et al. 2004), most likely secondary
to causing an elevation of serum lipids (Calvert
and Wille 1996). Dioxin exposure has also
been shown to be associated with an increased
risk of diabetes in Vietnam Ranch Hand
Veterans (Michalek et al. 1999) and among
individuals living near a dioxin-contaminated
Superfund site (Cranmer et al. 2000). Dioxin
alters other endocrine functions, causing
endometriosis in monkeys (Rier and Foster
2002) and possibly in humans (Eskenazi et al.
2002). Dioxin is an antiestrogen and, as such,
impairs prostate development (Roman and
Peterson 1998), spermatogenesis, and repro-
ductive capability in rodents (Mably et al.
1992). In human studies, Vreugdenhil et al.
(2002) showed that higher prenatal dioxin lev-
els were associated with more feminized play
behavior in both boys and girls. High paternal
exposure to dioxin alters the sex ratio of off-
spring, with signiﬁcantly more girls than boys
being born (Mocarelli et al. 2000; Ryan et al.
2002). Thus, although much attention has
been focused on cancer as an end point of
TCDD exposure, a number of other diseases
of equal or perhaps greater public health
importance are associated with exposure to
complex mixtures of DLCs.
In previous studies (Hites et al. 2004a,
2004b), we reported that concentrations of
dioxins, PCBs, polybrominated diphenyl
ethers, and pesticides, including toxaphene and
dieldrin, among other contaminants, are sig-
niﬁcantly higher in farm-raised salmon than in
wild Paciﬁc salmon and that salmon raised on
European farms have signiﬁcantly higher cont-
aminant concentrations than do those raised
on North and South American farms. Human
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[Online 9 February 2005]cancer risks associated with consumption of
farmed salmon contaminated with PCBs,
toxaphene, and dieldrin are higher than can-
cer risks associated with consumption of simi-
lar quantities of wild salmon. As a result,
risk-based consumption advice for farmed
salmon is more stringent than consumption
advice for wild salmon (Hites et al. 2004a).
Here we present risk-based consumption
information for farmed and wild salmon cont-
aminated with dioxins, furans, and dioxin-like
PCBs (DLCs). We developed consumption
levels based on the tolerable daily intake (TDI)
of the World Health Organization (WHO
1998), which assesses dioxin health risks via a
toxicity equivalency (TEQ) approach that
characterizes dioxins and DLCs as 17 2,3,7,8-
substituted polychlorinated dibenzodioxins
(PCDDs) and polychlorinated dibenzofurans
(PCDFs), and the 12 non-ortho and mono-
ortho PCBs. Risk-based consumption advice
was also developed via the methods of the
U.S. EPA (2002).
Materials and Methods
Sample collection and preparation methods
have been previously described in detail
(Hites et al. 2004a). DLCs were measured in
farmed and wild salmon collected from
around the world. Atlantic salmon were pur-
chased through wholesalers from farms in the
world’s eight major farming regions or as ﬁl-
lets from supermarkets in 16 North American
and European cities. Five wild species of
Paciﬁc salmon (chum, Oncorhyncus ket; coho,
Oncorhyncus kisutch; chinook, Oncorhyncus
tshawytscha; pink, Oncorhyncus  gorbuscha;
sockeye, Oncorhyncus  nerka) were also col-
lected and analyzed. We did not analyze wild
Atlantic salmon because few are available
commercially, nor did we analyze farmed
Paciﬁc salmon because they are not raised in
any substantial amounts (FAO 2004; Kocik
and Brown 2002).
All samples were shipped to the analytical
laboratory (AXYS Analytical, Sidney, British
Columbia, Canada) fresh or frozen on ice or
gel packs. Fish were thawed and inspected by
a ﬁsheries biologist to verify species. Each ﬁsh
was weighed and its length measured; then it
was filleted to give two skin-on fillets. We
analyzed skin-on ﬁllets because most salmon
are sold at retail outlets with the skin on. In
each case, the fillets from three fish were
ground and reground together to make a
homogeneous composite.
We used U.S. EPA methods (U.S. EPA
1994, 1999) to measure dioxin and dioxin-like
PCB congeners (Hites et al. 2004a). All meth-
ods were based on gas chromatographic high-
resolution mass spectrometry with isotopically
labeled internal standards. Chlorinated
dibenzo-p-dioxins and dibenzofurans were
measured using U.S. EPA Method 1613 (U.S.
EPA 1994), which was calibrated with an extra
standard that was one-ﬁfth the concentration
of the method requirement. Dioxin concentra-
tions were reported as TEQs assuming non-
detects were zero and using WHO TEQ
factors. Dioxin-like PCB congeners were quan-
titated using U.S. EPA Method 1668A (U.S.
EPA 1999); this technique is an isotope-dilu-
tion, congener-specific method for the
12 dioxin-like congeners and an internal stan-
dard method for the remaining 197 congeners.
Dioxin-like PCB concentrations were reported
as TEQs assuming nondetects were zero. The
reported DLC results are the sum of the chlori-
nated dioxin/furan TEQ and the dioxin-like
PCB TEQ, the latter always being the major
contributor to the total.
Analyses were conducted in accordance
with AXYS’s accredited quality assurance/
quality control program as described by Hites
et al (2004a). All blank measurements were
near or below detection limits (typically
< 0.02 pg/g for dioxins/furans, < 0.2 pg/g for
dioxin-like PCBs); hence, blank values were
not subtracted from the sample measure-
ments. Certiﬁed reference samples were ana-
lyzed periodically to demonstrate analytical
accuracy.
We present DLC-associated health risks
by developing fish consumption rates for
farmed and wild salmon that limit DLC
intake to one of two levels—the lower range
of the WHO TDI or a 20% increment above
the average (65 pg TEQ/day) U.S. adult
DLC daily intake (20% selected arbitrarily).
We also assessed cancer risk associated with
DLC exposure by using the U.S. EPA’s draft
cancer slope factor for dioxins of 1 × 10–3/pg
TEQ/kg/day (U.S. EPA 2002).
The WHO (1998) developed a TDI for
DLCs from all sources of 1–4 pg TEQ/kg
body weight (bw) per day (hereafter,
pg TEQ/kg/day). The TDI was derived from
LOAELs (lowest observed adverse effect levels)
for a variety of adverse responses in experimen-
tal animals that occur in a relatively narrow
dose range (WHO 1998). Long-term human
daily intakes of 14–37 pg/kg/day associated
with the LOAELs were adjusted by an uncer-
tainty factor of 10 to establish the TEQ-based
TDI of 1–4 pg TEQ/kg/day. The WHO
(1998) consultation stressed that the upper
range of the TDI (4 pg TEQ/kg/day) “should
be considered a maximal tolerable intake on a
provisional basis and that the ultimate goal is
to reduce human intake levels below 1 pg
TEQ/kg bw/day.” The U.S. Agency for Toxic
Substances and Disease Registry (ATSDR
1998) has also established a minimal risk level
for DLCs of 1 pg TEQ/kg/day.
The U.S. EPA (2002) used a “margin-of-
exposure” approach to assess the health risks
of exposure to DLCs. The U.S. EPA also sug-
gested that the average DLC intake in U.S.
adults is approximately 65 pg TEQ/day, and
this intake level and associated body burden
are within a factor of 100, and in some cases
within a factor of 10, of human no observable
adverse effect levels (NOAELs) and related
end points. As a result, the U.S. EPA has not
proposed a reference dose for dioxins in its
reassessment. Rather, the U.S. EPA (2002)
suggests that evaluation of incremental expo-
sures associated with speciﬁc sources of DLCs
relative to background may be appropriate.
To that end, we assessed the incremental
exposure to DLCs above background associ-
ated with consumption of farmed and wild
salmon as a function of contaminant concen-
tration in salmon tissues and meal frequency.
Meal frequencies were chosen to limit DLC
intake to 20% above the background intake.
Choice of an incremental increase of 20%
greater than background was not intended to
imply acceptable or unacceptable exposure
levels; rather, the increment was chosen arbi-
trarily to compare health-based consumption
rates for farmed and wild salmon.
All risk-based ﬁsh consumption rates were
developed assuming an average meal size of
227 g (0.5 lb), consistent with U.S. EPA
(2004) risk assessment methods for contami-
nants in fish, and an adult body weight of
70 kg. Risk-based meal consumption rates are
based on average DLC concentrations for ﬁsh
from each farming region, city, and species of
wild Paciﬁc salmon as reported by Hites et al.
(2004a).
Results
Location-specific, risk-based meal consump-
tion rates for farmed and wild salmon are pre-
sented in Figure 1. To limit DLC intake to
the lower end of the WHO TDI (1 pg
TEQ/kg/day), most farmed salmon must be
consumed at rates of < 10 meals/month. For
salmon from northern European farms, meal
frequencies are generally < 4 meals/month.
These consumption rates assume that DLC
exposure is from farmed salmon only and
does not account for myriad other DLC
exposure routes [Institute of Medicine (IOM)
2003]; thus, total human DLC exposure at
the consumption rates shown in Figure 1 is
likely higher than 1 pg TEQ/kg/day. In con-
trast, most wild Pacific salmon can be con-
sumed at very high rates, in many cases
> 1 meal/day, to limit DLC exposure to 1 pg
TEQ/kg/day.
Consumption rates are directly related to
contaminant concentrations in the tissues of
farmed and wild salmon. DLC concentrations
are significantly and considerably higher in
farmed salmon than in wild salmon, and in
salmon from European farms than in salmon
from North and South American farms
(Hites et al. 2004a). DLCs are present in
other foods, but the levels in farmed salmon
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salmon) are greater than reported in any other
food in the Food and Drug Administration
(FDA) Total Diet Survey, including meats,
poultry, and dairy products (IOM 2003,
Appendix Table B-2).
Consumption of salmon at rates that limit
DLC intake to 1 pg TEQ/kg/day results in a
100% incremental increase over background
(65 pg TEQ/day) DLC intake for an adult
weighing 70 kg. Restriction of DLC intake to
an incremental increase of 20% greater than
background requires a substantial reduction
in meal frequency of farmed and wild salmon
(Figure 1). Meal frequencies are lowest for
salmon with the highest DLC concentrations,
such as those from European farms. For
example, meal frequencies for farmed salmon
from Scotland, the Faroe Islands, and
Norway, as well as farmed salmon sold in
European markets, is < 1 meal/month. Only
wild Paciﬁc salmon can be consumed at rates
of ≥ 4 meals/month (1 meal/week), with con-
sumption rates for the least contaminated wild
salmon > 16 meals/month (4 meals/week).
Application of the U.S. EPA draft cancer
slope factor (U.S. EPA 2002) for DLCs in tis-
sues of farmed and wild salmon results in
upper-bound cancer risks as high as 1 × 10–3
(1 in 1,000) when fish are consumed at
rates that result in DLC intake of 1 pg
TEQ/kg/day; that is, cancer risks of 1 × 10–3
result from consumption of most farmed
salmon at a meal frequency of greater than
twice per week. When salmon are consumed
at meal frequencies that limit DLC intake to
20% above background exposure (Figure 1),
cancer risk declines to 2 × 10–4. To achieve a
cancer risk of 1 × 10–5 (the middle of the U.S.
EPA’s acceptable risk range; U.S. EPA 2000),
consumption of farmed Atlantic salmon must
be effectively eliminated and consumption of
wild salmon must be restricted generally to
less than one meal per month.
Discussion
Many farmed Atlantic salmon contain dioxin
concentrations that, when consumed at mod-
est rates, pose elevated cancer and noncancer
health risks. However, dioxin and DLCs are
just one suite of many organic and inorganic
contaminants and contaminant classes in the
tissues of farmed salmon (Foran et al. 2004;
Hites et al. 2004a, 2004b), and the cumula-
tive health risk of exposure to these com-
pounds via consumption of farmed salmon is
likely even higher. As we have shown here,
modest consumption of farmed salmon cont-
aminated with DLCs raises human exposure
levels above the lower end of the WHO TDI,
and considerably above background intake
levels for adults in the United States.
Although both farmed and wild salmon
are sold commercially within and outside the
United States, the FDA has not established a
tolerance or other administrative level of
DLCs for commercially sold ﬁsh or for other
foods. However, the FDA has used 1 ppt as a
level of concern for dioxins in chicken, eggs,
and catfish (FDA 2004). The European
Commission Scientific Committee on Food
(2000) established a temporary tolerable
intake of 7 pg TEQ/kg/week for DLCs (effec-
tively the lower end of the WHO TDI),
which results in advice to restrict salmon con-
sumption identical to TDI-based consump-
tion restrictions in Figure 1.
Our assessment of contaminants in
farmed and wild salmon (Foran et al. 2004;
Hites et al. 2004a, 2004b) has been criticized
for not including potential contaminant
reductions, and commensurate reduction in
health risks, that may result from proper ﬁsh
preparation and cooking procedures. This
issue is complex and has been examined in
salmon from the Great Lakes as well as in
other species (Salama et al. 1998; Skea et al.
1979; Voiland et al. 1991; Zabik et al. 1995,
1996; Zabik and Zabik 1999). These studies
demonstrate that removal of skin (and associ-
ated fat, lateral line, and belly ﬂap) and some
cooking methods do, in some cases, reduce
contaminant levels in fish. However, the
amount of contaminant reduction is highly
variable within species, among species, and
among contaminants.
Most of these studies suffer from small
sample sizes, questionable data analyses,
inconsistent analytical techniques, inconsis-
tent data presentation, and variability in ini-
tial and postintervention contaminant
concentrations within and among species,
preparation techniques, and cooking tech-
niques. Deﬁciencies in study design and vari-
ability in contaminant reductions preclude
development of a useful quantitative correc-
tion factor for the effects of preparation and
cooking on contaminant burden. As a result,
reductions in exposure and risk associated
with reduction in contaminant concentra-
tions from preparation and cooking cannot be
evaluated quantitatively; thus, we have not
incorporated the effects of cooking and prepa-
ration in our risk assessments.
Despite these limitations, it may be pru-
dent public health practice to prepare and cook
ﬁsh in ways that reduce fatty components of
fish tissue. However, consumers will accrue
beneﬁts, if any, of ﬁsh preparation and cooking
methods only if they are aware of and use the
proper methods. An extensive education pro-
gram in the Great Lakes basin was designed to
inﬂuence ﬁsh preparation, cooking, and con-
sumption behavior with the goal of reducing
human exposure to contaminants in the tissues
of Great Lakes sport fish. This program was
based on dissemination of consumption, clean-
ing, and cooking advice regionally—primarily
via written material (e.g., brochures distributed
with fishing licenses)—and locally through
more intensive initiatives such as communica-
tion with consumer groups and health care
professionals. The results of these programs are
not compelling. Tilden et al. (1997) surveyed
> 8,300 residents of the Great Lakes basin to
determine their consumption behaviors (for
Article | Foran et al.
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(purchased retail)
Wild Pacific salmon
Figure 1. Risk-based consumption advice for Atlantic salmon purchased from farms, farmed Atlantic salmon
purchased from retail stores, and wild Paciﬁc salmon. Solid bars indicate the number of meals per month to
limit dioxin intake to 1 pg TEQ/kg/day, the lower end of the WHO TDI (1–4 pg TEQ/kg/day). Patterned bars
indicate the number of meals per month to limit dioxin intake to 20% above the average (65 pg TEQ/day) U.S.
adult intake level. Abbreviations: AK, Alaska; BC, British Columbia; SE, southeastern. Edible tissue levels of
DLCs were reported by Hites et al. (2004a). Wild salmon capped at a practical consumption rate of
60 meals/month or approximately 2 meals/day.Great Lakes sport fish) and their awareness
and use of preparation, cooking, and con-
sumption advice. Despite extensive education
efforts, slightly fewer than half of Great Lakes
ﬁsh consumers were aware of the advice, and
awareness was significantly lower in females
(39%) and in races other than “white” (22%).
Even fewer changed behavior as a result of
the advice.
The IOM (2003) and the American Heart
Association (2005) recommend frequent con-
sumption of fish (at least 2 meals/week) to
attain the beneﬁts associated with intake of the
omega-3 fatty acids. Consumption of omega-3
fatty acids is important for cardiac health in
individuals of ages where they are vulnerable
to heart attacks. However, health risks of can-
cer and a variety of noncancer health effects
resulting from consumption of DLCs and
other contaminants may outweigh the beneﬁts
of consumption of certain types of seafood.
This is particularly true in girls and young
women (IOM 2003) who are exceptionally
vulnerable to DLC-associated adverse effects
because of their long half-life in the human
body and because these compounds have seri-
ous adverse effects on the developing fetus.
Our data provide opportunities to reduce
DLC intake and still gain the benefits of
ingestion of omega-3 fatty acids by choosing
fish, including most wild salmon, that have
lower concentrations of DLCs or by eating
other foods, such as various nuts, oils, and
vegetables that are high in these healthy fats.
Our work also supports the IOM recom-
mendation to “interrupt the cycle of DLCs
through forage, animal feed, and food-produc-
ing animals” (IOM 2003). The feed of farmed
salmon appears to be the source of DLCs and
many other organic contaminants to these ﬁsh
(Hites et al 2004a). Changes in the composi-
tion of feed that result in reduction of organic
contaminant concentrations should result in
commensurate contaminant reductions in the
edible tissues of farmed salmon. We have also
supported labeling that identiﬁes all salmon as
farmed or wild and that identiﬁes the country
of origin so consumers can reduce exposure to
DLCs and other contaminants by making
informed choices about the ﬁsh they choose to
purchase and consume.
It is apparent that consumption advice for
DLC-contaminated fish varies considerably
when based on risk assessment or exposure
reduction methods of different national and
international agencies. To some degree this
reﬂects scientiﬁc uncertainty as well as the eco-
nomic forces that inﬂuence consumption advi-
sories and other risk and exposure reduction
methods. However, divergent consumption
recommendations that result from inconsis-
tent risk assessment and exposure reduction
methods exacerbate consumer confusion.
These considerations point to the urgent need
for methods that are consistent among
national and international agencies to develop
consumption advice for contaminated ﬁsh as
well as other foods.
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tions have begun to elucidate the major
sources of fluoroquinolone (FQ)-resistant
Campylobacter infections in the United States.
Major findings include the following: a)a n
increasing proportion of isolates collected in
the United States from human Campylobacter
infections are resistant to FQs [Allos 2001;
Centers for Disease Control and Prevention
(CDC) 2003; Nachamkin et al. 2002];
b) studies of human stool samples taken
before FQ therapy indicate that most of the
infections were resistant before treatment
(Gaunt and Piddock 1996; Smith et al. 1999);
c) epidemiologic studies indicate that fresh
poultry products are the major sources of
Campylobacter infections in humans (Harris
et al. 1986; Neimann et al. 2003); d) FQ-
resistant Campylobacter populations develop
quickly in Campylobacter-infected chickens
that are treated with FQs (McDermott et al.
2002); and e) in the United States, consumer-
ready fresh poultry products are commonly
contaminated with FQ-resistant strains of
Campylobacter (Ge et al. 2003). It has been
inferred from these ﬁndings that a large num-
ber of FQ-resistant Campylobacter infections in
humans are the result of FQ use in the poultry
house. Some of the strongest evidence to sup-
port this connection comes from a recent
study of human campylobacteriosis in
Australia, where despite regular clinical use of
FQs and normal rates of Campylobacter infec-
tion, there are no conﬁrmed cases of domesti-
cally acquired FQ-resistant campylobacteriosis
(Unicomb et al. 2003). The authors concluded
that this dramatic phenomenon is likely related
to Australia’s prohibition of FQ use in poultry
production.
FQs, Sara Flox WSP (saraﬂoxacin water-
soluble powder; Abbott Laboratories, North
Chicago, IL) and Baytril (enroﬂoxacin; Bayer
Corporation, Shawnee Mission, KS), have
been approved for use in the United States to
control Escherichia coli infections in broiler
chickens since 1995 and 1996, respectively
[Food and Drug Administration (FDA) 1995,
1996]. In October 2000, the FDA’s Center
for Veterinary Medicine announced that it
intended to withdraw approval for FQs in
poultry production because new evidence had
shown that it may not be safe for human
health (FDA 2000a). In March 2004, the
FDA’s regulation was upheld in court, but
Bayer has appealed this decision. Although
this battle continues, Baytril continues to be
marketed for use as a drinking water additive
for ﬂock-wide application in broiler produc-
tion. The exact number of birds treated with
Baytril annually is not publicly available, but
Bayer estimated that < 1% of the American
poultry flock was treated with the drug in
2001 (Bayer Healthcare 2004). Given the
enormous scale of the American poultry ﬂock
(~ 8.4 billion in 2001), this estimate indicates
that up to 84 million birds may be treated
with Baytril annually [U.S. Department of
Agriculture (USDA) 2002]. In February
2002, in response to public concerns regard-
ing FQ use in poultry production, two major
U.S. producers, Tyson and Perdue, separately
announced that they would stop using FQs in
drinking water to treat poultry ﬂocks (Perdue
Farms 2002; Tyson Foods 2002).
A recent survey of Campylobacter from raw
poultry products indicated that 35% of iso-
lates were resistant to ciproﬂoxacin (CIP) (Ge
et al. 2003). Ge et al. (2003) used standard
FDA methodologies in which Campylobacter
colonies were isolated on Campylobacter
media and a small sample of colonies (typi-
cally no more than three) was tested for sus-
ceptibility to FQs. Because poultry products
are often contaminated with mixed popula-
tions of Campylobacter strains with differing
FQ susceptibilities, this assay has question-
able sensitivity, and the 35% ﬁgure reported
previously is considered to underestimate the
actual prevalence of FQ-resistant strains
(FDA 2000b).
In the present study, we performed a sur-
vey of fresh poultry products from two of the
countries largest conventional producers,
Tyson Foods and Perdue Farms, and two
“antibiotic-free” producers, Bell & Evans and
Eberly. Campylobacter strains were isolated
using standard FDA methodology and also by
a modiﬁed method that included FQ-supple-
mented agar medium to identify resistant
strains among a mix of susceptible and resis-
tant strains. We analyzed our results comparing
FQ-resistant Campylobacter carriage among the
two “antibiotic-free” and the two conventional
brands and tested the increased sensitivity
gained by using FQ-supplemented agar.
Materials and Methods
Sampling and enrichment. Fresh chicken
products from two antibiotic-free producers,
Bell & Evans (Fredericksburg, PA; A) and
Eberly Poultry (Stevens, PA; B), and two con-
ventional producers, Perdue Farms (Salisbury,
MD; C), and Tyson Foods (Springdale, AR;
D), were purchased seven to eight times from
grocery stores in the Baltimore, Maryland,
area over the course of 10 weeks (from
25 February to 13 May 2003; Table 1). All
samples were purchased in packaging applied
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Fluoroquinolone-Resistant Campylobacter Isolates from Conventional
and Antibiotic-Free Chicken Products
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The use of ﬂuoroquinolones (FQs) in poultry production is an important issue in public health
today. In February 2002, two prominent U.S. poultry companies pledged to stop using FQs for
flock-wide treatment. One year later, we began a survey of Campylobacter isolates on chicken
products from these two companies and from two producers claiming total abstention from
antibiotic use. Using both standard isolation methods and new methods modified to enhance
detection of FQ-resistant Campylobacter, we compared rates of FQ-resistant Campylobacter
among these products. Four major ﬁndings were drawn from this study: a) antibiotic-free brands
were not more likely to be contaminated with Campylobacter; b) a high percentage of products
from the two conventional brands were contaminated with FQ-resistant Campylobacter (43 and
96%); c) these conventional brands had signiﬁcantly higher odds of carrying resistant strains com-
pared with antibiotic-free products; and d) supplementing media with FQs increased the sensitivity
of detecting FQ-resistant strains among mixed populations of Campylobacter, thus reducing a bias
toward underestimating the prevalence of FQ-resistant Campylobacter on samples. These results
suggest that FQ resistance may persist in the commercial poultry environment in the absence of
FQ-selective pressure and that these strains contaminate a larger proportion of foods than reported
previously. Key words: bacterial, Campylobacter, chickens, drug resistance, drugs, ﬂuoroquinolones,
food microbiology, methods, poultry, veterinary. Environ Health Perspect 113:557–560 (2005).
doi:10.1289/ehp.7647 available via http://dx.doi.org/ [Online 2 February 2005]